Broad portfolio for biologics, including cell and gene therapy products
Digitally connected Drug Delivery Devices for self-administration
New performance levels for the right choice of product
Sustainability by design from development to production
Düsseldorf, January 10, 2024. Gerresheimer, an innovative system and solution provider and a global partner for the pharma, biotech and cosmetic industry will present its comprehensive portfolio of containment solutions, drug delivery systems and digital solutions in areas such as therapy support at this year’s Pharmapack. The company’s presence at the trade fair will focus on specialized primary packaging solutions for sensitive innovative drugs such as biopharmaceuticals, including cell and gene therapy products — from COP injection vials for cryogenic temperatures through to medication pumps. Thanks to its extensive portfolio and long-standing expertise, Gerresheimer delivers the right solution for every drug and every production requirement, including RTF solutions that minimize risks during the filling process, reduce overall costs and accelerate time to market. Alongside its own efforts to increase sustainability, Gerresheimer helps customers take this topic into account as early as during the product development stage through its EcoDesign approach. On top of that, the company provides sterilization and RTF packaging options that are more environmentally friendly. Gerresheimer will be presenting its solutions at Pharmapack Paris from January 24 - 25 in hall 7.2, booth F60 and in the Innovation Gallery. Gerresheimer experts will also share insights and expertise in innovation track presentations and learning lab sessions.